Protein/peptide and DNA vaccine delivery by targeting C-type lectin receptors

References

• Zelensky AN, Gready JE. The C-type lectin-like domain superfamily. FEBS J.272(24), 6179–6217 (2005).
   PubMed Web of Science ®Google Scholar
• Drickamer K, Fadden AJ. Genomic analysis of C-type lectins. Biochem. Soc. Symp.(69), 59–72 (2002).
   Google Scholar
• Ampel NM, Nelson DK, Li L et al. The mannose receptor mediates the cellular immune response in human coccidioidomycosis. Infect. Immun.73(4), 2554–2555 (2005).
   Google Scholar
• Lloyd DH, Viac J, Werling D, Reme CA, Gatto H. Role of sugars in surface microbe–host interactions and immune reaction modulation. Vet. Dermatol.18(4), 197–204 (2007).
   PubMed Web of Science ®Google Scholar
• Colmenares M, Puig-Kroger A, Pello OM, Corbi AL, Rivas L. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem.277(39), 36766–36769 (2002).
   PubMedGoogle Scholar
• de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB. Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol.80(7), 3477–3486 (2006).
   PubMed Web of Science ®Google Scholar
• Pollara G, Kwan A, Newton PJ, Handley ME, Chain BM, Katz DR. Dendritic cells in viral pathogenesis: protective or defective? Int. J. Exp. Pathol.86(4), 187–204 (2005).
   PubMed Web of Science ®Google Scholar
• Soilleux EJ. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe? Clin. Sci. (Lond.)104(4), 437–446 (2003).
   PubMed Web of Science ®Google Scholar
• Soilleux EJ, Sarno EN, Hernandez MO et al. DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect? J. Pathol.209(2), 182–189 (2006).
   Web of Science ®Google Scholar
• Apostolopoulos V, Pietersz GA, Tsibanis A et al. Pilot Phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]. Breast Cancer Res.8(3), R27 (2006).
   PubMed Web of Science ®Google Scholar
• Levitz SM, Specht CA. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res.6(4), 513–524 (2006).
   PubMed Web of Science ®Google Scholar
• Mahnke K, Guo M, Lee S et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell. Biol.151(3), 673–684 (2000).
   PubMed Web of Science ®Google Scholar
• Sheng KC, Kalkanidis M, Pouniotis DS et al. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur. J. Immunol.38(2), 424–436 (2008).
   PubMed Web of Science ®Google Scholar
• Chieppa M, Bianchi G, Doni A et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol.171(9), 4552–4560 (2003).
   PubMed Web of Science ®Google Scholar
• Nonaka M, Ma BY, Murai R et al. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated lewis glycans impair the function and differentiation of monocyte-derived dendritic cells. J. Immunol.180(5), 3347–3356 (2008).
   PubMedGoogle Scholar
• Shan M, Klasse PJ, Banerjee K et al. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog.3(11), e169 (2007).
   PubMed Web of Science ®Google Scholar
• Torrelles JB, Azad AK, Schlesinger LS. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J. Immunol.177(3), 1805–1816 (2006).
   PubMed Web of Science ®Google Scholar
• Lam JS, Huang H, Levitz SM. Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS ONE2(10), e1009 (2007).
   PubMedGoogle Scholar
• Engering AJ, Cella M, Fluitsma D et al. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol.27(9), 2417–2425 (1997).
   PubMed Web of Science ®Google Scholar
• Tan MC, Mommaas AM, Drijfhout JW et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol.27(9), 2426–2435 (1997).
   PubMed Web of Science ®Google Scholar
• Engering A, Geijtenbeek TB, van Vliet SJ et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol.168(5), 2118–2126 (2002).
   PubMed Web of Science ®Google Scholar
• Feinberg H, Mitchell DA, Drickamer K, Weis WI. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science294(5549), 2163–2166 (2001).
   PubMed Web of Science ®Google Scholar
• Pietrella D, Bistoni G, Corbucci C, Perito S, Vecchiarelli A. Candida albicans mannoprotein influences the biological function of dendritic cells. Cell Microbiol.8(4), 602–612 (2006).
   PubMedGoogle Scholar
• Sheng KC, Pouniotis DS, Wright MD et al. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology118(3), 372–383 (2006).
   PubMed Web of Science ®Google Scholar
• Nagaoka K, Takahara K, Tanaka K et al. Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in Gram-negative bacteria. Int. Immunol.17(7), 827–836 (2005).
   Google Scholar
• Doz E, Rose S, Nigou J et al. Acylation determines the Toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem.282(36), 26014–26025 (2007).
   PubMed Web of Science ®Google Scholar
• Quesniaux VJ, Nicolle DM, Torres D et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J. Immunol.172(7), 4425–4434 (2004).
   PubMed Web of Science ®Google Scholar
• Dzionek A, Sohma Y, Nagafune J et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J. Exp. Med.194(12), 1823–1834 (2001).
   PubMed Web of Science ®Google Scholar
• Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ et al. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production. Blood111(8), 4245–4253 (2008).
   PubMedGoogle Scholar
• Chen CH, Floyd H, Olson NE et al. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood107(4), 1459–1467 (2006).
   PubMed Web of Science ®Google Scholar
• Dillon S, Agrawal S, Banerjee K et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest.116(4), 916–928 (2006).
   PubMed Web of Science ®Google Scholar
• Valera I, Fernandez N, Trinidad AG et al. Costimulation of dectin-1 and DC-SIGN triggers the arachidonic acid cascade in human monocyte-derived dendritic cells. J. Immunol.180(8), 5727–5736 (2008).
   Google Scholar
• Yadav M, Schorey JS. The β-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood108(9), 3168–3175 (2006).
   PubMed Web of Science ®Google Scholar
• Kantchev EA, Chang CC, Chang DK. Direct Fmoc/tert-Bu solid phase synthesis of octamannosyl polylysine dendrimer–peptide conjugates. Biopolymers84(2), 232–240 (2006).
   Google Scholar
• Kel J, Oldenampsen J, Luca M, Drijfhout JW, Koning F, Nagelkerken L. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Am. J. Pathol.170(1), 272–280 (2007).
   PubMed Web of Science ®Google Scholar
• Mommaas AM, Mulder AA, Jordens R et al. Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/lysosomal compartment for loading of HLA class II molecules. Eur. J. Immunol.29(2), 571–580 (1999).
   Google Scholar
• Brimble MA, Kowalczyk R, Harris PW, Dunbar PR, Muir VJ. Synthesis of fluorescein-labelled O-mannosylated peptides as components for synthetic vaccines: comparison of two synthetic strategies. Org. Biomol. Chem.6(1), 112–121 (2008).
   Google Scholar
• Moyle PM, Olive C, Ho MF et al. Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines. J. Med. Chem.50(19), 4721–4727 (2007).
   PubMedGoogle Scholar
• Lam JS, Mansour MK, Specht CA, Levitz SM. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J. Immunol.175(11), 7496–7503 (2005).
   PubMed Web of Science ®Google Scholar
• Luong M, Lam JS, Chen J, Levitz SM. Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine25(22), 4340–4344 (2007).
   PubMed Web of Science ®Google Scholar
• Singh R, Bandyopadhyay D. MUC1: a target molecule for cancer therapy. Cancer Biol. Ther.6(4), 481–486 (2007).
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Pietersz GA, McKenzie IF. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine14(9), 930–938 (1996).
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc. Natl Acad. Sci. USA92(22), 10128–10132 (1995).
   PubMed Web of Science ®Google Scholar
• Lofthouse SA, Apostolopoulos V, Pietersz GA, Li W, McKenzie IF. Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen. Vaccine15(14), 1586–1593 (1997).
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Barnes N, Pietersz GA, McKenzie IF. Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine18(27), 3174–3184 (2000).
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Pietersz GA, Gordon S, Martinez-Pomares L, McKenzie IF. Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur. J. Immunol.30(6), 1714–1723 (2000).
   PubMed Web of Science ®Google Scholar
• Zhong G, Wang J, Xu M et al. Enhanced maturation and functional capacity of dendritic cells induced by mannosylated L2 domain of ErbB2 receptor. Scand. J. Immunol.62(2), 108–116 (2005).
   Google Scholar
• Aarnoudse CA, Bax M, Sanchez-Hernandez M, Garcia-Vallejo JJ, van Kooyk Y. Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells. Int. J. Cancer122(4), 839–846 (2008).
   PubMed Web of Science ®Google Scholar
• Srinivas O, Larrieu P, Duverger E et al. Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting. Bioconjug. Chem.18(5), 1547–1554 (2007).
   PubMed Web of Science ®Google Scholar
• Agnes MC, Tan A, Jordens R et al. Strongly increased efficiency of altered peptide ligands by mannosylation. Int. Immunol.10(9), 1299–1304 (1998).
   PubMed Web of Science ®Google Scholar
• Charalambous A, Oks M, Nchinda G, Yamazaki S, Steinman RM. Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin. J. Immunol.177(12), 8410–8421 (2006).
   PubMed Web of Science ®Google Scholar
• Mahnke K, Qian Y, Fondel S, Brueck J, Becker C, Enk AH. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res.65(15), 7007–7012 (2005).
   PubMed Web of Science ®Google Scholar
• Do Y, Park CG, Kang YS et al. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells. Eur. J. Immunol.38(1), 20–29 (2008).
   PubMed Web of Science ®Google Scholar
• Bozzacco L, Trumpfheller C, Siegal FP et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc. Natl Acad. Sci. USA104(4), 1289–1294 (2007).
   PubMed Web of Science ®Google Scholar
• Trumpfheller C, Caskey M, Nchinda G et al. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl Acad. Sci. USA105(7), 2574–2579 (2008).
   PubMed Web of Science ®Google Scholar
• Trumpfheller C, Finke JS, Lopez CB et al. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med.203(3), 607–617 (2006).
   PubMed Web of Science ®Google Scholar
• Ramakrishna V, Treml JF, Vitale L et al. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J. Immunol.172(5), 2845–2852 (2004).
   PubMed Web of Science ®Google Scholar
• He LZ, Crocker A, Lee J et al. Antigenic targeting of the human mannose receptor induces tumor immunity. J. Immunol.178(10), 6259–6267 (2007).
   PubMed Web of Science ®Google Scholar
• He LZ, Ramakrishna V, Connolly JE et al. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β. Clin. Cancer Res.10(6), 1920–1927 (2004).
   PubMed Web of Science ®Google Scholar
• Ramakrishna V, Vasilakos JP, Tario JD Jr, Berger MA, Wallace PK, Keler T. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells. J. Transl. Med.5, 5 (2007).
   PubMed Web of Science ®Google Scholar
• Neethling FA, Ramakrishna V, Keler T, Buchli R, Weidanz JA. Assessing vaccine potency using TCRmimic antibodies. Vaccine (2008).
   Google Scholar
• Idoyaga J, Cheong C, Suda K et al. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol.180(6), 3647–3650 (2008).
   Google Scholar
• Carter RW, Thompson C, Reid DM, Wong SY, Tough DF. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol.177(4), 2276–2284 (2006).
   PubMed Web of Science ®Google Scholar
• Delneste Y, Magistrelli G, Gauchat J et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity17(3), 353–362 (2002).
   PubMed Web of Science ®Google Scholar
• Tacken PJ, de Vries IJ, Gijzen K et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood106(4), 1278–1285 (2005).
   PubMed Web of Science ®Google Scholar
• Kretz-Rommel A, Qin F, Dakappagari N et al.In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models. J. Immunother.30(7), 715–726 (2007).
   PubMed Web of Science ®Google Scholar
• Dakappagari N, Maruyama T, Renshaw M et al. Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses. J. Immunol.176(1), 426–440 (2006).
   PubMed Web of Science ®Google Scholar
• Corbett AJ, Caminschi I, McKenzie BS et al. Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional “danger”. Eur. J. Immunol.35(10), 2815–2825 (2005).
   PubMed Web of Science ®Google Scholar
• Luca ME, Kel JM, van Rijs W, Wouter Drijfhout J, Koning F, Nagelkerken L. Mannosylated PLP(139–151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis. J. Neuroimmunol.160(1–2), 178–187 (2005).
   Google Scholar
• Kel JM, de Geus ED, van Stipdonk MJ, Drijfhout JW, Koning F, Nagelkerken L. Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. Int. Immunol.20(1), 117–127 (2008).
   Google Scholar
• Mukhopadhaya A, Hanafusa T, Jarchum I et al. Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl Acad. Sci. USA105(17), 6374–6379 (2008).
   PubMed Web of Science ®Google Scholar
• Pietersz GA, Tang CK, Apostolopoulos V. Structure and design of polycationic carriers for gene delivery. Mini Rev. Med. Chem.6(12), 1285–1298 (2006).
   PubMed Web of Science ®Google Scholar
• Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem.263(29), 14621–14624 (1988).
   PubMed Web of Science ®Google Scholar
• Gijzen K, Cambi A, Torensma R, Figdor CG. C-type lectins on dendritic cells and their interaction with pathogen-derived and endogenous glycoconjugates. Curr. Protein Pept. Sci.7(4), 283–294 (2006).
   PubMed Web of Science ®Google Scholar
• Diebold SS, Plank C, Cotten M, Wagner E, Zenke M. Mannose receptor-mediated gene delivery into antigen presenting dendritic cells. Somat. Cell. Mol. Genet.27(1–6), 65–74 (2002).
   PubMedGoogle Scholar
• Diebold SS, Kursa M, Wagner E, Cotten M, Zenke M. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J. Biol. Chem.274(27), 19087–19094 (1999).
   PubMed Web of Science ®Google Scholar
• Erbacher P, Bousser MT, Raimond J, Monsigny M, Midoux P, Roche AC. Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum. Gene Ther.7(6), 721–729 (1996).
   PubMed Web of Science ®Google Scholar
• Ferkol T, Perales JC, Mularo F, Hanson RW. Receptor-mediated gene transfer into macrophages. Proc. Natl Acad. Sci. USA93(1), 101–105 (1996).
   PubMed Web of Science ®Google Scholar
• Diebold SS, Lehrmann H, Kursa M, Wagner E, Cotten M, Zenke M. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum. Gene Ther.10(5), 775–786 (1999).
   PubMed Web of Science ®Google Scholar
• Kim TH, Jin H, Kim HW, Cho MH, Cho CS. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol. Cancer Ther.5(7), 1723–1732 (2006).
   PubMed Web of Science ®Google Scholar
• Fajac I, Grosse S, Briand P, Monsigny M. Targeting of cell receptors and gene transfer efficiency: a balancing act. Gene Ther.9(11), 740–742 (2002).
   PubMed Web of Science ®Google Scholar
• Grosse S, Tremeau-Bravard A, Aron Y, Briand P, Fajac I. Intracellular rate-limiting steps of gene transfer using glycosylated polylysines in cystic fibrosis airway epithelial cells. Gene Ther.9(15), 1000–1007 (2002).
   Google Scholar
• Hattori Y, Kawakami S, Lu Y, Nakamura K, Yamashita F, Hashida M. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration. J. Gene Med.8(7), 824–834 (2006).
   PubMed Web of Science ®Google Scholar
• Liang WW, Shi X, Deshpande D, Malanga CJ, Rojanasakul Y. Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis. Biochim. Biophys. Acta1279(2), 227–234 (1996).
   PubMed Web of Science ®Google Scholar
• Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther.4(8), 823–832 (1997).
   PubMed Web of Science ®Google Scholar
• Tang C-K, Sheng K-C, Pouniotis D et al. Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses. Vaccine26(31), 3827–3834 (2008).
   PubMed Web of Science ®Google Scholar
• Kim TH, Nah JW, Cho MH, Park TG, Cho CS. Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles. J. Nanosci. Nanotechnol.6(9–10), 2796–2803 (2006).
   PubMed Web of Science ®Google Scholar
• Lu Y, Kawakami S, Yamashita F, Hashida M. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Biomaterials28(21), 3255–3262 (2007).
   PubMed Web of Science ®Google Scholar
• Jain S, Singh P, Mishra V, Vyas SP. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett.101(1), 41–49 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou X, Liu B, Yu X et al. Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine. J. Control. Release121(3), 200–207 (2007).
   PubMed Web of Science ®Google Scholar
• Sasaki S, Fukushima J, Arai H et al. Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol.27(12), 3121–3129 (1997).
   PubMed Web of Science ®Google Scholar
• Toda S, Ishii N, Okada E et al. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-γ antibody. Immunology92(1), 111–117 (1997).
   PubMed Web of Science ®Google Scholar
• Xiang SD, Scholzen A, Minigo G et al. Pathogen recognition and development of particulate vaccines: does size matter? Methods40(1), 1–9 (2006).
   PubMed Web of Science ®Google Scholar
• Hattori Y, Kawakami S, Nakamura K, Yamashita F, Hashida M. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J. Pharmacol. Exp. Ther.318(2), 828–834 (2006).
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Morimoto M, Saimoto H et al. Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages. Biotechnol. Lett.28(11), 815–821 (2006).
   PubMed Web of Science ®Google Scholar
• Sakurai F, Nishioka T, Yamashita F, Takakura Y, Hashida M. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system. Eur. J. Pharm. Biopharm.52(2), 165–172 (2001).
   PubMed Web of Science ®Google Scholar
• Hattori Y, Kawakami S, Suzuki S, Yamashita F, Hashida M. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun.317(4), 992–999 (2004).
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Higuchi Y, Kawakami S, Yamashita F, Nishikawa M, Hashida M. Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages. Biochim. Biophys. Acta1511(1), 134–145 (2001).
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Hyoudou K, Nishikawa M, Yamashita F, Hashida M. Serum mannan binding protein inhibits mannosylated liposome-mediated transfection to macrophages. Biochim. Biophys. Acta1570(3), 203–209 (2002).
   PubMed Web of Science ®Google Scholar
• Hattori Y, Suzuki S, Kawakami S, Yamashita F, Hashida M. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J. Control. Release108(2–3), 484–495 (2005).
   PubMed Web of Science ®Google Scholar
• Demangel C, Zhou J, Choo AB, Shoebridge G, Halliday GM, Britton WJ. Single chain antibody fragments for the selective targeting of antigens to dendritic cells. Mol. Immunol.42(8), 979–985 (2005).
   PubMedGoogle Scholar
• Nchinda G, Kuroiwa J, Oks M et al. The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J. Clin. Invest.118(4), 1427–1436 (2008).
   PubMed Web of Science ®Google Scholar
• Korokhov N, de Gruijl TD, Aldrich WA et al. High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN. Cancer Biol. Ther.4(3), 289–294 (2005).
   PubMed Web of Science ®Google Scholar
• Karanikas V, Hwang LA, Pearson J et al. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan–MUC1 fusion protein. J. Clin. Invest.100(11), 2783–2792 (1997).
   PubMed Web of Science ®Google Scholar
• Karanikas V, Lodding J, Maino VC, McKenzie IF. Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Clin. Cancer Res.6(3), 829–837 (2000).
   PubMed Web of Science ®Google Scholar
• Karanikas V, Thynne G, Mitchell P et al. Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J. Immunother.24(2), 172–183 (2001).
   Web of Science ®Google Scholar
• Apostolopoulos V, Lofthouse SA, Popovski V, Chelvanayagam G, Sandrin MS, McKenzie IF. Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat. Biotechnol.16(3), 276–280 (1998).
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Osinski C, McKenzie IF. MUC1 cross-reactive Gal α(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat. Med.4(3), 315–320 (1998).
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Sandrin MS, McKenzie IF. Mimics and cross reactions of relevance to tumour immunotherapy. Vaccine18(3–4), 268–275 (1999).
   PubMedGoogle Scholar
• Loveland BE, Zhao A, White S et al. Mannan–MUC1-pulsed dendritic cell immunotherapy: a Phase I trial in patients with adenocarcinoma. Clin. Cancer Res.12(3 Pt 1), 869–877 (2006).
   PubMed Web of Science ®Google Scholar
• Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med.196(12), 1627–1638 (2002).
   PubMed Web of Science ®Google Scholar
• Bonifaz LC, Bonnyay DP, Charalambous A et al.In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med.199(6), 815–824 (2004).
   PubMed Web of Science ®Google Scholar
• Valladeau J, Duvert-Frances V, Pin JJ et al. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J. Immunol.167(10), 5767–5774 (2001).
   PubMed Web of Science ®Google Scholar
• Zhou T, Chen Y, Hao L, Zhang Y. DC-SIGN and immunoregulation. Cell. Mol. Immunol.3(4), 279–283 (2006).
   PubMed Web of Science ®Google Scholar
• Carter RW, Thompson C, Reid DM, Wong SY, Tough DF. Induction of CD8+ T cell responses through targeting of antigen to dectin-2. Cell. Immunol.239(2), 87–91 (2006).
   Google Scholar
• Kanazawa N. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. J. Dermatol. Sci.45(2), 77–86 (2007).
   PubMed Web of Science ®Google Scholar
• McGreal EP, Rosas M, Brown GD et al. The carbohydrate-recognition domain of dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology16(5), 422–430 (2006).
   PubMed Web of Science ®Google Scholar
• Fanning SL, George TC, Feng D et al. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-α production. J. Immunol177(9), 5829–5839 (2006).
   PubMed Web of Science ®Google Scholar
• Fujikado N, Saijo S, Yonezawa T et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat Med.14(2), 176–180 (2008).
   PubMed Web of Science ®Google Scholar
• Ryan EJ, Marshall AJ, Magaletti D et al. Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4. J. Immunol.169(10), 5638–5648 (2002).
   PubMed Web of Science ®Google Scholar
• Sobanov Y, Bernreiter A, Derdak S et al. A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex. Eur. J. Immunol.31(12), 3493–3503 (2001).
   PubMedGoogle Scholar